Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.

The goal of this open label randomized controlled trial is to evaluate the efficacy of an intervention through health education based on the Chronic Care Model's implementation to increase therapeutic adherence in patients with secondary prevention for cardiovascular disease. The main questions it aims to answer are: * Null hypothesis (H0): In patients in cardiovascular secondary prevention, an intervention based on the application of the Chronic Care Model does not improve therapeutic adherence to the 3 preventive drugs: Angiotensin converting enzyme inhibitors/Angiotensin II receptor blockers, acetylsalicylic acid, and statins. * Alternative hypothesis (H1): In patients in cardiovascular secondary prevention, an intervention based on the application of the Chronic Care Model improves therapeutic adherence to the 3 preventive drugs: Angiotensin converting enzyme inhibitors/Angiotensin II receptor blockers, acetylsalicylic acid, and statins. Researchers will compare intervention group (health education, use of mobile phones, personalized dosage system) to the control group (routine follow-up).

NCT Number	NCT06510946
Lead Sponsor	Universidad Miguel Hernandez de Elche
Conditions	Cardiovascular Diseases, Chronic Disease, Secondary Prevention, Coronary Disease
Enrollment	90 participants
Start Date	2025-01
Primary Completion	2025-12 (estimated)
Study Completion	2026-01 (estimated)
Updated on ClinicalTrials.gov	2024-07-19